Ｄivision of Health Medical Intelligence,
Laboratory of Sequence Analysis,
Human Genome Center
Institute of Medical Science,
University of Tokyo
An article about a conversation Prof. Imoto had with Shoji Kono, CSO of Microsoft Japan, at "Genomics & AI The Future of the Healthcare Industry: Data & AI to Support the Development of Bioinformatics" has been published.
Postdoctoral researcher Heryanto and Associate Professor Yaozhong Zhang proposed a new modeling formalism for annotating cell types from single-cell data using a supervised contrastive learning method, published by Scientific Reports.
D. student Mirei Seki et al. proposed a new imputation method in time series microbiome data using a diffusion model. The paper was orally presented as a refereed paper at the International Conference on Bioinformatics and Biomedicine (BIBM2023).
Prof. Imoto contributed an article titled "Cancer Whole Genome Analysis Project and Challenges of the Analysis Team" to the January issue of Clinical Oncology published by Kagaku-hyoronsya. The article explains the current status and future of the national project to link whole genome information to patient return.
November 25, 2022
Professor Imoto received the NPB Distinguished Service Award and the 2022 J-League Distinguished Service Award for his past advice to the NPB and J-League on COVID-19 infection control.
The November issue of Experimental Medicine published a collection of commentary papers that I planned with Prof. Uematsu titled "Is Phage Therapy a Chief Card against Multidrug-Resistant Bacteria?" with five papers; (1) Introduction (2) Metagenome analysis and next-generation phage therapy (3) Modified phage therapy (4) Development of gene-targeted CRISPR-Cas-loaded antimicrobial phage and (5) Practical application of phage therapy based on clinical trials. Please take a look.
Dr. Noriaki Sato has been appointed as an Assistant Professor of Division of Health Medical Intelligence.
The AWS Genomics Roundtable "Using the Cloud for Next-Generation Genomic Medicine Based on Whole Genome Analysis" is now available.
The Hitachi Academic System Study Group, of which Prof. Imoto serves as vice president, is scheduled to hold its 47th meeting on Monday, September 26, at 1:30 p.m. The theme is "What Data Utilization Infrastructure is Necessary for Data Strategy? The meeting will be held online and there is no charge for participation. Please join us.
Contributed an article titled "Prospects for Stratified Medicine from Metagenomic Analysis" to "Autoimmune Diseases: Toward a New Era of Stratification" in the Experimental Medicine supplement issue. The article describes the development of novel therapies using information from the intestinal microbiota metagenome. Co-authored with Prof. Uematsu and Associate Prof. Fujimoto.
The second story of "MARCO x Kao Special Conversations" with Mr. Fujii of Kao Corporation, entitled "Bringing the Results of the Tokyo Olympics to the Field of Professional Sports. Toward the Resumption of Social Activities" is now available.
As part of the "Project for Promotion of Human Resource Development on Whole Genome Analysis of Cancer" commissioned by the Ministry of Health, Labour and Welfare, "Lectures on Genome Analysis of Cancer in Clinical Practice" will be held as in the previous year. Prof. Imoto is cooperating as the chairperson of the review committee. Associate Professor Katayama will also serve as a lecturer.
A conversation with Kenkichi Fujii, General Manager of Kao Corporation's Research and Development Division, regarding cooperation in infection control measures for the Tokyo Olympics and other events, is now available.
A conversation between Dr. Kuniaki Miyake, Chief Medical Officer of DeNA and leader of the MHLW's coronary measures, and Prof. Imoto is now available on the DeNA website.
Associate Professor Yao-zhong Zhang will present a paper "On the application of BERT models for nanopore methylation detection" at IEEE International Conference on Bioinformatics and Biomedicine. This is deep learning development to identify structural variants from long read sequencing data.
A doctor course student, Yunjie Liu, presents his paper "Discovering microbe functionality in human disease with a gene-ontology-aware model" at the international conference Biological ontologies and knowledge bases (BiOK). This is a research on the development of metagenomic data analysis methods that are attracting attention around the world.
The full text of the discussion between Prof. Imoto and IBM CTO Morimoto at Day 4 of IBM Think Summit Japan (10/5-10/8)
"Cutting-edge Technology for the Future" is now available. We are talking about future technologies in COVID-19,
cancer genomic medicine, and gut microbiome research.
MARCO (MAss gathering Risk COntrol and Communication) (Representative: Seiya Imoto), a volunteer research group for risk control and communication in large-scale gatherings, received the 2021 Good Practice Award from the Society for Risk Analysis, Japan.
The website of the 2016 Survey of Working Styles of Doctors (Survey of 100,000 Doctors, Principal Investigator: Imoto) was suspended due to the end of the survey, but due to the application of work style reforms for doctors in 2024. Reopened. Please note that the URL has changed.
Project Associate Professor Zhang has published a new deep learning model based on the deep segmentation model, UNet, for identifying single nucleotide level breakpoints of structural variants from nanopore sequencing data. The paper has been published in PLoS Computational Biology.
Japan COVID-19 Task Force, in which Professor Imoto participates,
discovers a promising candidate for a factor contributing to the severity of new coronavirus infections
in the Japanese population.
Our research paper, the first in the world to solve the mystery of fecal microbiota transplantation, was selected for the cover of Gastroenterology (Vol. 160, Issue 6), the premier journal of gastroenterology.
Prof. Imoto will give a talk at NVIDIA GPU Technology Conference (GTC). Title: "Exponential Evolution of Large-Scale Genomic Data Analysis Infrastructure Enabled by GPUs"
Prof. Imoto contributed to the March issue of the Journal of the Japanese Society of Internal Medicine with an article titled "Application of Artificial Intelligence (AI) to Clinical and Genomic Medicine".
We organized a symposium on data science of new coronavirus infections and cancer genomes. Please join us.
Prof. Imoto gave a presentation at Symposium Celebrating U-Tokyo x Google Partnership Toward "AI Symbiotic Future Society"
Prof. Imoto made a comment on infectious disease control in NHK news on January 22.
Professor Imoto received the J-League Awardｓ "Chairman's Special Award" for his contribution to the fight against corona.
Professor Imoto received the NPB Awards "NPB Special Award" for his contribution to the fight against corona.
PLATINUM STREET TIMES, a public relations magazine of the Institute of Medical Sciences, is published. Our metagenome research is also introduced.
We contributed to Nutrition Reviews (Oxford University Press) under the title "Data science and precision health care".
Contributed an article "New Dimension Genomics for Next-Generation Genomic Medicine" to the November 2020 issue of Precision Medicine (front cover).
A research paper with Prof. Nakanishi was selected for the cover of Cell Metabolism (Vol.32, Issue 5) .
Prof. Imoto will give an educational talk at the 58th Annual Meeting of Japan Society for Healthcare Administration.
Our research of gut microbiome is introduced by NIKKEI Biotechnology.
Contribution a review "Towards AI-enhanced genomic medicine" on IGAKUNO AYUMI (Journal of Clinical and Experiemtal Medicne)
"The Road to Compilation of One Hundred and Fifty Years of History" on the occasion of the web publication of Centennial History of the University of Tokyo
The achievements of ICGC PanCancer were introduced in the official residence magazine (WE ARE TOMODACHI).